Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer (Q46308248)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer |
scientific article |
Statements
1 reference
Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer (English)
1 reference
1 reference
John V Heymach
1 reference
Roy S Herbst
1 reference
Luis Paz-Ares
1 reference
Martin Sebastian
1 reference
David J Stewart
1 reference
Wilfried E E Eberhardt
1 reference
Anantbhushan A Ranade
1 reference
Graham Cohen
1 reference
Jose Manuel Trigo
1 reference
Alan B Sandler
1 reference
Philip D Bonomi
1 reference
Annetta D Krebs
1 reference
James Vasselli
1 reference
Bruce E Johnson
1 reference
20 October 2008
1 reference
26
1 reference
33
1 reference
5407-5415
1 reference